Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-10-004057
Filing Date
2010-01-28
Accepted
2010-01-28 12:06:41
Documents
5
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 v172099_10ka.htm 10-K/A 369999
2 v172099_ex31-1.htm EX-31.1 14457
3 v172099_ex31-2.htm EX-31.2 14448
4 v172099_ex32-1.htm EX-32.1 8488
5 v172099_ex32-2.htm EX-32.2 8212
  Complete submission text file 0001144204-10-004057.txt   417120
Mailing Address 18 TECHNOLOGY, SUITE 130 IRVINE CA 92618
Business Address 18 TECHNOLOGY, SUITE 130 IRVINE CA 92618 949-336-7111
NURX PHARMACEUTICALS, INC. (Filer) CIK: 0001174228 (see all company filings)

EIN.: 870681500 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52037 | Film No.: 10552779
SIC: 2833 Medicinal Chemicals & Botanical Products